Nuvalent (NUVL) Non Operating Income (2020 - 2026)

Nuvalent (NUVL) reported Non Operating Income of $10.3 million for Q1 2026, down 0.88% on a YoY basis from $10.4 million in Q1 2025, and up 276.27% quarter-over-quarter from -$5.8 million in Q4 2025.

Nuvalent (NUVL) Non Operating Income (2020 - 2026) Analysis & Trends

Nuvalent has reported Non Operating Income for 7 years, with the latest figure at $10.3 million in Q1 2026.

  • For the quarter ending Q1 2026, Non Operating Income fell 0.88% year-over-year to $10.3 million; the trailing twelve-month figure through Mar 2026 stood at -$91000.0 (down 100.41% YoY), and the FY2024 full-year result was $20.4 million, down 12.45% from the prior year.
  • Non Operating Income for Q1 2026 stood at $10.3 million, up from -$5.8 million in the prior quarter.
  • The five-year high for Non Operating Income was $11.7 million in Q4 2024, with the low at -$9.6 million in Q3 2025.
  • Historically, Non Operating Income has averaged $3.4 million across 5 years, with a median of $5.0 million in 2023.
  • Annual changes were most pronounced in 2022 — Non Operating Income soared 67100.0% — and 2024, when it plunged 255.2%.
  • Nuvalent's Non Operating Income stood at $3.2 million in 2022, then jumped by 156.45% to $8.1 million in 2023, then jumped by 43.73% to $11.7 million in 2024, then slumped by 149.89% to -$5.8 million in 2025, then soared by 276.27% to $10.3 million in 2026.
  • The last three Non Operating Income figures came in at $10.3 million (Q1 2026), -$5.8 million (Q4 2025), and -$9.6 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Op. Inc. (Qtr)
1 Alterity Therapeutics 762,369.55 Bn 762,369.51 Bn - -
2 Belite Bio 55,096.00 Bn 55,096.00 Bn - 5.75 Mn
3 Quantum Biopharma 17,755.80 Bn 17,755.79 Bn - -
4 Legend Biotech 3,486.00 Bn 3,485.71 Bn 242.10 Mn -
5 Akari Therapeutics 1,737.42 Bn 1,737.41 Bn - 444,000.00
6 Evaxion A 1,551.28 Bn 1,551.26 Bn - -
7 Psyence Biomedical 227.32 Bn 227.31 Bn - -
8 Vertex Pharmaceuticals 110.84 Bn 103.59 Bn 2.59 Bn -
9 Abivax 91.71 Bn 91.71 Bn - 9.35 Mn
10 Nuvalent 9.70 Bn 9.70 Bn - 10.30 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 10.30 Mn
Dec 31, 2025 -5.84 Mn
Sep 30, 2025 -9.61 Mn
Jun 30, 2025 5.06 Mn
Mar 31, 2025 10.39 Mn
Dec 31, 2024 11.71 Mn
Sep 30, 2024 -7.97 Mn
Jun 30, 2024 8.15 Mn
Mar 31, 2024 8.49 Mn
Dec 31, 2023 8.15 Mn
Sep 30, 2023 5.14 Mn
Jun 30, 2023 4.97 Mn
Mar 31, 2023 5.02 Mn
Dec 31, 2022 3.18 Mn
Sep 30, 2022 672,000.00
Jun 30, 2022 267,000.00
Mar 31, 2022 139,000.00
Dec 31, 2021 -546,000.00
Sep 30, 2021 1,000.00
Jun 30, 2021 12,000.00